Logotype for Tata Elxsi Limited

Tata Elxsi (TATAELXSI) Q1 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Tata Elxsi Limited

Q1 24/25 earnings summary

9 Jul, 2026

Executive summary

  • Q1 FY25 saw steady growth, with revenues from operations at ₹92,645.52 lakhs (INR 926.5 crores), up 2.4% QoQ and 8.4% YoY in constant currency terms, led by the Transportation segment now over 50% of SDS revenue.

  • EBITDA was ₹25,230 lakhs (INR 252.3 crores), flat YoY, impacted by a one-time expense of ₹1,978 lakhs (INR 19.78 crores) for a contribution to the Progressive Electoral Trust.

  • Transportation business led growth, while healthcare saw a decline due to project renewal delays; media and communication showed resilience with slight growth.

  • Strong deal pipeline and continued investments in digital, AI, and GenAI technologies across verticals, targeting 25% of staff to be AI-ready by December.

  • Audited financial results for the quarter ended June 30, 2024, were approved by the Board with an unmodified audit opinion from the statutory auditors.

Financial highlights

  • Revenue from operations: ₹92,645.52 lakhs (INR 926.5 crores), up 2.4% QoQ and 8.4% YoY in constant currency.

  • EBITDA: ₹25,230 lakhs (INR 252.3 crores), flat YoY (+0.3%).

  • PBT: ₹25,240 lakhs (INR 252.4 crores), down from ₹26,240 lakhs in the previous quarter.

  • PAT: ₹18,407.99 lakhs (INR 184.1 crores), down 2.5% YoY and 6.5% QoQ.

  • EPS (Basic) at ₹29.56, down 6.5% QoQ and 2.5% YoY.

Outlook and guidance

  • Management maintains guidance for FY25 revenue growth to exceed FY24, despite healthcare headwinds in H1.

  • Margin guidance remains at 28-29% for the year, with levers in place to manage wage hikes and costs.

  • Confident outlook for Q2 FY25, driven by a robust deal pipeline and expansion with strategic customers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more